Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Ahsan R (mars 2006). ”Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study”. J. Nerv. Ment. Dis. 194 (3): sid. 164–172. doi:10.1097/01.nmd.0000202575.79453.6e. PMID 16534433.
Gregg L, Barrowclough C, Haddock G (maj 2007). ”Reasons for increased substance use in psychosis”. Clinical Psychology Review 27 (4): sid. 494–510. doi:10.1016/j.cpr.2006.09.004. PMID 17240501.
Whitaker, R. (2001) "Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill". Perseus Publishing. ISBN 0-7382-0385-8.
Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. (1987) The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144(6), 727–35.
Verdoux, H., & van Os, J. (2002) Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research, 54(1–2), 59–65.
Bebbington, P., Kuipers, L. (1994) The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychological Medicine, 24 (3),707–18.
Van Os J. (2004) Does the urban environment cause psychosis? British Journal of Psychiatry, 184 (4), 287–288.
Sundquist K, Frank G, Sundquist J. (2004) Urbanisation and incidence of psychosis and depression: Follow-up study of 4.4 million women and men in Sweden. British Journal of Psychiatry, 184 (4), 293–298.
Kulhara P. (1994) Outcome of schizophrenia: some transcultural observations with particular reference to developing countries. European Archives of Psychiatry and Clinical Neuroscience, 244(5), 227–35.
Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Ahsan R (mars 2006). ”Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study”. J. Nerv. Ment. Dis. 194 (3): sid. 164–172. doi:10.1097/01.nmd.0000202575.79453.6e. PMID 16534433.
Gregg L, Barrowclough C, Haddock G (maj 2007). ”Reasons for increased substance use in psychosis”. Clinical Psychology Review 27 (4): sid. 494–510. doi:10.1016/j.cpr.2006.09.004. PMID 17240501.
Sagud M, Mihaljević-Peles A, Mück-Seler D, et al. (september 2009). ”Smoking and schizophrenia”. Psychiatria Danubina 21 (3): sid. 371–375. PMID 19794359.